Future Microbiol. 2012;7(12):1401-1422. † Genetic resistance determinants (penA, mtrR and penB) elucidated. MLST: Multilocus sequence typing; ND: Not determined; NG ...

Health officials have long warned that gonorrhea is becoming more and more resistant to all the antibiotic drugs we have to fight it. Last year, the US reached a grim landmark: For the first time, two ...

The strain, which was just found in Canada for the first time, is resistant to one of the last remaining drugs used to treat it. Rates of gonorrhea are rising in the United States: From 2015 to 2016, ...

The emergence of Neisseria gonorrhoeae strains resistant to ceftriaxone, the last reliable treatment, poses significant public health threats. The global spread of the FC428 clone, carrying penA ...

A unique strain of gonorrhea identified in two residents in Massachusetts showed little or no response to five classes of antibiotics, health officials said Jan. 19. The lack of response is something ...

Public health officials says they have found two cases of gonorrhea that appear to have reduced susceptibility to every kind of antibiotic available to treat them. It's the first time strains of ...

A one-dose oral drug called zoliflodacin has proven highly effective against gonorrhoea in a major international trial. The ...

The bacteria behind the sexually transmitted disease gonorrhea is known for developing antibiotic resistance. Now there are two new treatment options.

For the first time in decades, the U.S. Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection ...

Gepotidacin, an investigational antibiotic, proved noninferior to dual therapy for the treatment of uncomplicated urogenital gonorrhea, according to results of the phase III EAGLE-1 trial. The ...

A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a new study published Monday in The Lancet. The drug, called gepotidacin, ...